海王英特龍2023年第三季度報告

Third Q%5Cuarterly Report 2022第三季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

2018 Third Q%5Cuarterly Report 第三季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

2023 First Q%5Cuarterly Report 第一季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

Third Q%5Cuarterly Report 2017第三季度報告 2017 香港聯(lián)合交易所有限公司（「聯(lián)交所」）創(chuàng)業(yè)板（「創(chuàng)業(yè)板」）特色 創(chuàng)業(yè)板的定位，乃為相比起其他在聯(lián)交所上市的公司帶有較高投資風險的公司提供一個上市的市場。有意投資的人士應(yīng)了解投資 於該等公司的潛在風險，並應(yīng)經(jīng)過審慎周詳?shù)目紤]後

海王英特龍秉持「健康成就未來」的理念，以現(xiàn)代生物技術(shù)與藥物制劑技術(shù)為創(chuàng)新平臺，發(fā)展細胞因子類蛋白質(zhì)治療藥物和預(yù)防用生物制品，創(chuàng)建以自主知識產(chǎn)權(quán)產(chǎn)品研發(fā)和專業(yè)化營銷能力為代表的核心競爭力，逐步確立國內(nèi)市

海王英特龍秉持「健康成就未來」的理念，以現(xiàn)代生物技術(shù)與藥物制劑技術(shù)為創(chuàng)新平臺，發(fā)展細胞因子類蛋白質(zhì)治

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s